| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 13.01▼ | 13.03▼ | 13.05▼ | 13.00▲ | 11.98▲ |
| MA10 | 13.02▼ | 13.08▼ | 13.13▼ | 12.76▲ | 10.98▲ |
| MA20 | 13.02▼ | 13.15▼ | 13.14▼ | 11.92▲ | 11.63▲ |
| MA50 | 13.06▼ | 13.09▼ | 12.80▲ | 11.21▲ | 6.81▲ |
| MA100 | 13.17▼ | 12.73▲ | 12.52▲ | 11.39▲ | 4.41▲ |
| MA200 | 13.12▼ | 12.24▲ | 11.39▲ | 7.65▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.031▼ | -0.051▼ | 0.089▲ | -0.150▼ |
| RSI | 45.808▼ | 45.153▼ | 48.881▼ | 58.887▲ | 62.363▲ |
| STOCH | 19.823▼ | 16.338▼ | 16.183▼ | 70.862 | 56.690 |
| WILL %R | -79.167▼ | -91.803▼ | -63.433 | -24.859▲ | -37.429 |
| CCI | -10.753 | -87.179 | -93.240 | 83.164 | 80.124 |
|
Monday, August 03, 2026 04:00 AM
ADC is cleared for clinical development Designed to selectively deliver pan-RAS(ON) inhibition to tumors while minimizing systemic toxicity. IND submissions to U.S. FDA and China NMPA are in process ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/08/26 | 13.125 | 13.27 | 12.965 | 13.00 | 109,343 |
| 04/08/26 | 12.10 | 13.88 | 12.10 | 13.00 | 179,057 |
| 03/08/26 | 13.00 | 13.41 | 12.70 | 12.99 | 216,575 |
| 31/07/26 | 13.00 | 13.28 | 12.465 | 13.00 | 120,404 |
| 30/07/26 | 12.3801 | 13.13 | 11.67 | 13.00 | 157,635 |
| 29/07/26 | 12.69 | 12.69 | 12.00 | 12.11 | 86,241 |
| 28/07/26 | 11.97 | 12.88 | 11.51 | 12.69 | 200,794 |
| 27/07/26 | 12.77 | 12.8559 | 11.908 | 12.06 | 127,789 |
| 24/07/26 | 13.15 | 13.15 | 12.04 | 12.50 | 130,567 |
| 23/07/26 | 13.25 | 13.42 | 12.975 | 13.22 | 145,027 |
|
|
||||
|
|
||||
|
|